Non Invasive Ventilation (NIV) Related Practices, Monitoring of the NIV Treatment Effect and of the Patient's Comfort
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by University of Lausanne Hospitals.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Prof. Philippe Jolliet, University of Lausanne Hospitals
First received: September 20, 2012
Last updated: September 24, 2012
Last verified: September 2012
The practices and processes related to the administration of noninvasive ventilation (NIV) in the adult intensive care unit (ICU) of the University hospital of Lausanne will be recorded by an investigator at the bedside. The effect of the NIV treatment on various respiratory parameters ( respiratory rate, expired tidal volume, minute ventilation) will also be recorded using a pneumotachograph. Finally patient's comfort during NIV treatment will be evaluated.
Respiratory Failure Requiring Non Invasive Ventilation
||Observational Model: Cohort
Time Perspective: Prospective
||Observation of Non Invasive Ventilation (NIV) Related Practices, Monitoring of the NIV Treatment Effect and of the Patient's Comfort During NIV
Primary Outcome Measures:
- Documentation of practices and processes related to NIV treatment [ Designated as safety issue: No ]
Documentation of practices and processes related to NIV administration in the adult intensive care unit(type of ventilator used, type of interface chosen, initial settings, organization of the care team and interactions between caregivers).
Secondary Outcome Measures:
- Patient's Respiratory comfort [ Designated as safety issue: No ]
Patient's respiratory comfort during NIV will be assessed both by the patients themselves with a visual analogic scale and by the investigator.
- Ventilatory parameters [ Designated as safety issue: No ]
Tidal volume, respiratory rate, inspiratory time, expiratory time and maximal and mean airway pressure will be measured from the continuous recording of airway pressure and flow obtained with a pneumotachograph.
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||June 2013 (Final data collection date for primary outcome measure)
Patients requiring NIV
Patients requiring NIV because of acute respiratory failure
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Adult patients hospitalized in the CHUV intensive care unit who require non invasive ventilation because of respiratory failure.
- Respiratory failure
- Therapeutic treatment by NIV required
- Age < 18 years old
- Prophylactic NIV treatment
- Continuous Positive Airway Pressure (CPAP)treatment
- Denied consent
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01692509
|Intensive care and burn unit, University Hospital of Lausanne
|Lausanne, Switzerland |
|Contact: Philippe Jolliet, Professor +41 79 556 16 50 firstname.lastname@example.org |
|Contact: Lise Piquilloud, MD +41 79 556 76 42 email@example.com |
|Principal Investigator: Philippe Jolliet, Professor |
|Sub-Investigator: Lise Piquilloud-Imboden, MD |
|Sub-Investigator: Jean-Pierre Revelly, MD |
|Sub-Investigator: Julien Simons |
University of Lausanne Hospitals
||Philippe Jolliet, Professor
||University of Lausanne Hospitals
No publications provided
||Prof. Philippe Jolliet, Main investigator, University of Lausanne Hospitals
History of Changes
|Other Study ID Numbers:
||NIV related practices
|Study First Received:
||September 20, 2012
||September 24, 2012
||Switzerland: Laws and standards
Keywords provided by University of Lausanne Hospitals:
Non invasive ventilation
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on November 20, 2014
Respiratory Tract Diseases